颈、胸上段食管癌以介入性化疗为主的综合治疗  

Intervention chemotherapy with subsidiary treatment of upper part of esophageal carcinoma

作　　者：陈彤宇[1] 杜建伟[1] 方立德[1] 

机构地区：[1]上海第二医科大学第九人民医院胸外科,200011

出　　处：《介入放射学杂志》2000年第3期161-162,共2页Journal of Interventional Radiology

摘　　要：目的　探索颈、胸上段食管癌介入治疗的疗效及其在综合治疗中的作用。方法　自 1995年 1月至 1999年 1月 ,收治 30例患者采用以胸廓内动脉为径路 ,锁骨下动脉或甲状颈干的区域性药盒灌注的介入性化疗 ,合并放疗 ,免疫治疗及手术切除的综合治疗。结果　临床症状包括梗噎、呕吐、疼痛、声嘶及异物感均有明显改善 ,颈部淋巴结缩小明显 ,CR +PR达 70 % ,最长生存达 18个月。结论　此方法具有创伤小 。Objective To study the effect of intervention chemotherapy with combined treatment subsidiary for carcinoma of esophagus in the part of cervical and superior thoracic regions. Methods From January 1995 to January 1999, 30 cases were treated. The pathway of the intervention chemotherapy was done through the intrathoracic artery to the subclavian artery or the thyrocervical trunk under fluoroscopic guidance, and then adopted regional perfusion combined with radiation therapy, immunological therapy and surgical resection. Results The symptoms of chocking, vomiting, hoarseness, pain and foreign body sensation had been distinctly improved with conspicuous shrinkage of cervical lymph nodes. The efficacy of CR+PR was 70%. The longest survival rate reached more than 18 months.Conclusions This method had the advantages of less trauma and better curative effect. The short term follow up showed satisfactorily.

关 键 词：食管癌 介入性化疗 综合治疗 

分 类 号：R735.1[医药卫生—肿瘤]